Walls, G. M. http://orcid.org/0000-0003-0845-9732
McConnell, L.
McAleese, J.
Murray, P.
Lynch, T. B.
Savage, K.
Hanna, G. G.
de Castro, D. Gonzalez
Funding for this research was provided by:
Experimental Cancer Medicine Centre Pump-Priming Fund (N/A)
Wellcome-Health Research Board Irish Clinical Academic Training Programme (N/A)
Article History
Received: 21 January 2020
Accepted: 25 May 2020
First Online: 29 May 2020
Ethics approval and consent to participate
: Patients were prospectively consented to undergo serial venepuncture during the first week of radical radiotherapy alone, and for their clinical data to be used in conjunction with plasma analysis.
: No de-anonymised patient information contained within.
: GH wishes to declare $2000.00 in speaker bureau fee from AstraZeneca (received August 2019) – donated directly to his institution. All other authors have no conflicts of interest to declare.